Things have changed: cell cycle dysregulation and smooth muscle cell dysfunction in atherogenesis

Area of Science:

• Cardiovascular Biology
• Aging Research
• Molecular Medicine

Background:

• Coronary artery disease (CAD) prevalence rises with age, with aging being an independent risk factor for atherogenesis.
• Increased reactive oxygen species (ROS) and oxidative damage are implicated in age-related atherogenesis, but precise molecular links are unclear.
• Vascular cell dysfunction in aging is associated with altered ROS production and dysregulated cell cycle events, with their interrelation needing further investigation.

Purpose of the Study:

• To explore the intricate links between aging, cell cycle regulation, and reactive oxygen species (ROS) generation.
• To elucidate the molecular mechanisms driving age-associated vascular cell dysfunction and atherosclerotic lesion formation.
• To synthesize recent findings on the interplay of aging, ROS, and cell cycle events in the context of vascular biology and atherogenesis.

Main Methods:

• Review and synthesis of recent scientific literature.
• Analysis of studies investigating vascular cell biology in aging.
• Examination of research on reactive oxygen species production and cell cycle regulation in atherogenesis.

Main Results:

• Aging is associated with increased oxidative stress and dysregulated cell cycle progression in vascular cells.
• These age-related changes in ROS production and cell cycle events are linked to vascular dysfunction.
• The precise molecular interplay between these factors in the development of atherosclerotic lesions requires further elucidation.

Conclusions:

• Aging significantly contributes to atherogenesis through mechanisms involving oxidative stress and cell cycle dysregulation.
• Understanding the link between ROS generation and cell cycle events is crucial for deciphering age-related vascular disease.
• Further molecular investigation is warranted to develop targeted interventions for age-associated cardiovascular disease.